Lupin Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-20

Stock price
₹2478.50
Market cap
1,13,317 Cr
Stock P/E
21.3
P/B
5.03
Dividend yield
0.5%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales4,814 Cr9,853 Cr15,050 Cr20,011 Cr5,600 Cr11,273 Cr5,768 Cr5,667 Cr6,268 Cr7,048 Cr7,168 Cr7,475 Cr
Operating expenses (approx.)3,935 Cr8,015 Cr12,145 Cr16,080 Cr4,292 Cr8,582 Cr4,358 Cr4,289 Cr4,462 Cr4,616 Cr5,218 Cr4,980 Cr
EBITDA879 Cr1,837 Cr2,905 Cr3,931 Cr1,309 Cr2,691 Cr1,410 Cr1,378 Cr1,806 Cr2,431 Cr1,950 Cr2,495 Cr
OPM %18.3%18.6%19.3%19.6%23.4%23.9%24.4%24.3%28.8%34.5%27.2%33.4%
Other income23 Cr62 Cr91 Cr120 Cr68 Cr86 Cr54 Cr57 Cr79 Cr90 Cr115 Cr141 Cr
Interest86 Cr166 Cr240 Cr312 Cr68 Cr139 Cr67 Cr89 Cr92 Cr108 Cr115 Cr120 Cr
Depreciation235 Cr483 Cr740 Cr1,197 Cr248 Cr505 Cr271 Cr393 Cr299 Cr317 Cr313 Cr447 Cr
Profit before tax559 Cr1,188 Cr1,925 Cr2,422 Cr993 Cr2,048 Cr1,071 Cr896 Cr1,416 Cr2,007 Cr1,522 Cr1,928 Cr
Tax %18.9%20.2%18.6%20.1%18.9%18.7%19.8%12.7%13.7%26.0%22.4%23.8%
Net profit453 Cr949 Cr1,567 Cr1,936 Cr806 Cr1,665 Cr859 Cr782 Cr1,221 Cr1,485 Cr1,181 Cr1,469 Cr
EPS (₹)₹9.94₹20.70₹34.17₹42.05₹17.58₹36.28₹18.75₹16.93₹26.70₹32.36₹25.74₹31.96

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales16,369 Cr15,375 Cr15,163 Cr16,405 Cr16,642 Cr20,011 Cr22,708 Cr27,958 CrSign in for TTM
Operating expenses (approx.)13,459 Cr13,288 Cr12,460 Cr15,977 Cr14,844 Cr16,200 Cr17,229 Cr19,275 CrSign in for TTM
EBITDA2,910 Cr2,086 Cr2,703 Cr429 Cr1,798 Cr3,811 Cr5,479 Cr8,683 CrSign in for TTM
OPM %17.8%13.6%17.8%2.6%10.8%19.0%24.1%31.1%Sign in for TTM
Other income713 Cr484 Cr136 Cr142 Cr73 Cr120 Cr196 Cr424 CrSign in for TTM
Interest308 Cr363 Cr141 Cr143 Cr274 Cr312 Cr295 Cr434 CrSign in for TTM
Depreciation1,085 Cr970 Cr887 Cr1,659 Cr881 Cr1,197 Cr1,169 Cr1,376 CrSign in for TTM
Profit before tax1,517 Cr753 Cr1,675 Cr-1,373 Cr716 Cr2,422 Cr4,015 Cr6,873 CrSign in for TTM
Tax %59.4%153.6%26.8%-10.0%37.5%20.1%17.7%22.1%Sign in for TTM
Net profit615 Cr-270 Cr1,228 Cr-1,509 Cr448 Cr1,936 Cr3,306 Cr5,355 CrSign in for TTM
EPS (₹)₹34.34₹-5.96₹27.09₹-33.65₹9.46₹42.05₹71.95₹116.75Sign in for TTM
Dividend payout %————40.8%9.4%11.0%10.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital91 Cr91 Cr91 Cr91 Cr91 Cr91 Cr91 Cr91 Cr
Reserves13,652 Cr12,446 Cr0.0000 Cr12,062 Cr12,452 Cr14,282 Cr17,112 Cr22,357 Cr
Borrowings2 Cr6 Cr299 Cr790 Cr4,244 Cr2,670 Cr3,310 Cr4,267 Cr
Other liabilities2,571 Cr3,202 Cr2,994 Cr3,373 Cr6,169 Cr6,954 Cr8,600 Cr11,585 Cr
Total liabilities19,690 Cr20,681 Cr21,859 Cr22,313 Cr22,956 Cr23,997 Cr29,205 Cr38,365 Cr
Fixed assets (net)3,067 Cr3,446 Cr3,556 Cr3,618 Cr4,645 Cr4,899 Cr5,148 Cr5,449 Cr
CWIP904 Cr695 Cr796 Cr774 Cr895 Cr596 Cr355 Cr695 Cr
Investments7,388 Cr7,456 Cr9,563 Cr9,511 Cr487 Cr1,048 Cr1,119 Cr3,641 Cr
Other assets9,507 Cr10,873 Cr9,630 Cr8,440 Cr12,453 Cr13,450 Cr16,804 Cr24,030 Cr
Total assets19,690 Cr20,681 Cr21,859 Cr22,313 Cr22,956 Cr23,997 Cr29,205 Cr38,365 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———1,082 Cr1,934 Cr3,490 Cr430 Cr7,546 Cr
Cash from investing———577 Cr-1,324 Cr-1,554 Cr-1,602 Cr-4,076 Cr
Cash from financing———-1,572 Cr-337 Cr-2,184 Cr1,732 Cr-846 Cr
Net cash flow———65 Cr273 Cr-248 Cr560 Cr2,624 Cr
Free cash flow (OCF − Capex)———177 Cr435 Cr2,562 Cr-1,252 Cr5,491 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %13.3%8.9%2001.1%-10.1%5.5%15.3%20.9%27.3%
ROE %4.4%-4.9%0.0%-12.6%3.4%13.3%19.0%23.7%
Debtor days123120105849886——
Inventory days312329360411443437447479
Days payable169208159175250261——
Cash conversion cycle265241306320291261447479
Debt / equity0.00010.00030.000.000.340.190.190.19
Current ratio4.754.243.722.381.341.581.871.90
Net debt / EBITDA0.000.000.000.001.680.440.320.01

Compare with peers

Loading peers…